Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Colorectal Neoplasms

Free Subscription Articles published in J Natl Cancer Inst Retrieve available abstracts of 49 articles: HTML format

Single Articles

August 2023
1. CHEN Z, Song W, Shu XO, Wen W, et al
   Novel insights into genetic susceptibility for colorectal cancer from transcriptome-wide association and functional investigation.
   J Natl Cancer Inst. 2023 Aug 26:djad178. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. REIF DE PAULA T, Keller DS
   A National Evaluation of Adjuvant Chemotherapy in pT4N0M0 Colon Cancer from the National Cancer Database.
   J Natl Cancer Inst. 2023 Aug 16:djad164. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. HELTE E, Save-Soderbergh M, Larsson SC, Martling A, et al
   Disinfection by-products in drinking water and risk of colorectal cancer: a population-based cohort study.
   J Natl Cancer Inst. 2023 Aug 8:djad145. doi: 10.1093.
   PubMed     Abstract available
   
   
   
4. BYRD DA, Fan W, Greathouse KL, Wu MC, et al
   The intratumor microbiome is associated with microsatellite instability.
   J Natl Cancer Inst. 2023;115:989-993.
   PubMed     Abstract available
   
   
   July 2023
5. ELZE L, van der Post RS, Vos JR, Mensenkamp AR, et al
   Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndrome.
   J Natl Cancer Inst. 2023;115:853-860.
   PubMed     Abstract available
   
   
   
6. ARONSON M, Gryfe R, Choi YH, Semotiuk K, et al
   Evaluating colonoscopy screening intervals in patients with Lynch syndrome from a large Canadian registry.
   J Natl Cancer Inst. 2023;115:778-787.
   PubMed     Abstract available
   
   
   June 2023
7. YEN T, Patel SG
   Symptoms and early-onset colorectal cancer: red flags are common flags!
   J Natl Cancer Inst. 2023 Jun 24:djad093. doi: 10.1093.
   PubMed    
   
   
   May 2023
8. BREGNI G, Trevisi E, Saude Conde R, Vanhooren M, et al
   Preexisting evidence and outcome of phase III trials in gastrointestinal oncology: a systematic review.
   J Natl Cancer Inst. 2023;115:505-513.
   PubMed     Abstract available
   
   
   
9. BILLER LH, Ng K
   The "Scope" of Colorectal Cancer Screening in Lynch Syndrome: Is There an Optimal Interval?
   J Natl Cancer Inst. 2023 May 4:djad074. doi: 10.1093.
   PubMed    
   
   
   
10. FRITZ CDL, Otegbeye EE, Zong X, Demb J, et al
    Red-flag Signs and Symptoms for Earlier Diagnosis of Early-Onset Colorectal Cancer.
    J Natl Cancer Inst. 2023 May 4:djad068. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2023
11. CORONADO GD, Ferrari RM, Barnes A, Castaneda SF, et al
    Characteristics of Patient Navigation Programs in the Cancer Moonshot ACCSIS Colorectal Cancer Screening Initiative.
    J Natl Cancer Inst. 2023 Feb 22:djad032. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. CROSS AJ, Gunter MJ
    Ultra-processed foods and colorectal neoplasia: is there a link?
    J Natl Cancer Inst. 2023;115:117-119.
    PubMed    
    
    
    
13. SELBY K, Sedki M, Levine E, Kamineni A, et al
    Test performance metrics for breast, cervical, colon and lung cancer screening: a systematic review.
    J Natl Cancer Inst. 2023 Feb 8:djad028. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2023
14. VOS JAM, Sert E, Busschers WB, Duineveld LAM, et al
    Detection of colon cancer recurrences during follow-up care by general practitioners versus surgeons.
    J Natl Cancer Inst. 2023 Jan 30:djad019. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. DAVIS LE, Mahar AL, Strumpf EC
    Agreement between individual and neighbourhood income measures in patients with colorectal cancer in Canada.
    J Natl Cancer Inst. 2023 Jan 27:djad017. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. MA W, Walker MM, Thuresson M, Roelstraete B, et al
    Cancer risk in patients with diverticular disease: A nationwide cohort study.
    J Natl Cancer Inst. 2023;115:62-70.
    PubMed     Abstract available
    
    
    
17. ROMESSER PB, Sanchez-Vega F, Joshua Smith J
    A methylation-based prognostic signature in stage II colorectal patients: Considerations for clinical adoption.
    J Natl Cancer Inst. 2023;115:8-11.
    PubMed    
    
    
    December 2022
18. HANG D, Wang L, Fang Z, Du M, et al
    Ultra-processed food consumption and risk of colorectal cancer precursors: results from three prospective cohorts.
    J Natl Cancer Inst. 2022 Dec 7:djac221. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2022
19. MURPHY N, Newton CC, Song M, Papadimitriou N, et al
    Body Mass Index and Molecular Subtypes of Colorectal Cancer.
    J Natl Cancer Inst. 2022 Nov 29:djac215. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. COLDITZ GA
    Combined individual participant data: highest level evidence on obesity and colorectal cancer molecular subtypes.
    J Natl Cancer Inst. 2022 Nov 29:djac216. doi: 10.1093.
    PubMed    
    
    
    
21. GALLICCHIO L, Devasia TP, Tonorezos E, Mollica MA, et al
    Estimation of the Number of Individuals Living With Metastatic Cancer in the United States.
    J Natl Cancer Inst. 2022;114:1476-1483.
    PubMed     Abstract available
    
    
    October 2022
22. SHIH YT, Xu Y, Bradley C, Giordano SH, et al
    Costs Around the First Year of Diagnosis for 4 Common Cancers Among the Privately Insured.
    J Natl Cancer Inst. 2022;114:1392-1399.
    PubMed     Abstract available
    
    
    September 2022
23. YU H, Wang X, Bai L, Tang G, et al
    DNA Methylation Profile in CpG-depleted Regions Uncovers a High-Risk Subtype of Early-stage Colorectal Cancer.
    J Natl Cancer Inst. 2022 Sep 28. pii: 6726193. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. ZHANG ER, Pfeiffer RM, Austin A, Clarke MA, et al
    Impact of HIV on Anal Squamous Cell Carcinoma Rates in the United States, 2001-2015.
    J Natl Cancer Inst. 2022;114:1246-1252.
    PubMed     Abstract available
    
    
    June 2022
25. CASTILHO JL, Bian A, Jenkins CA, Shepherd BE, et al
    CD4/CD8 Ratio and Cancer Risk Among Adults With HIV.
    J Natl Cancer Inst. 2022;114:854-862.
    PubMed     Abstract available
    
    
    
26. MOSS JL, Pinto CN, Srinivasan S, Cronin KA, et al
    Enduring Cancer Disparities by Persistent Poverty, Rurality, and Race: 1990-1992 to 2014-2018.
    J Natl Cancer Inst. 2022;114:829-836.
    PubMed     Abstract available
    
    
    
27. GOLDBERG RM, Adams R, Buyse M, Eng C, et al
    Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology.
    J Natl Cancer Inst. 2022;114:819-828.
    PubMed     Abstract available
    
    
    May 2022
28. 
    Correction to: Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests.
    J Natl Cancer Inst. 2022 May 20. pii: 6590000. doi: 10.1093.
    PubMed    
    
    
    
29. CASTANON A, Parmar D, Massat N, Sasieni P, et al
    Benefit of biennial faecal occult blood screening on colorectal cancer in England: A population-based case-control study.
    J Natl Cancer Inst. 2022 May 16. pii: 6586300. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. TIAN Y, Kim AE, Bien SA, Lin Y, et al
    Genome-Wide Interaction Analysis of Genetic Variants with Menopausal Hormone Therapy for Colorectal Cancer Risk.
    J Natl Cancer Inst. 2022 May 5. pii: 6581085. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2022
31. LADABAUM U, Church TR, Feng Z, Ransohoff DF, et al
    Counting Advanced Pre-Cancerous Lesions as True Positives When Determining Colorectal Cancer Screening Test Specificity.
    J Natl Cancer Inst. 2022 Feb 4. pii: 6522121. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. HEIN DM, Deng W, Bleile M, Kazmi SA, et al
    Racial and Ethnic Differences in Genomic Profiling of Early-Onset Colorectal Cancer.
    J Natl Cancer Inst. 2022 Feb 2. pii: 6520467. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2022
33. LEE LH, Davis L, Ylagan L, Omilian AR, et al
    Identification of a Subset of Stage I Colorectal Cancer Patients with High Recurrence Risk.
    J Natl Cancer Inst. 2022 Jan 30. pii: 6517508. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. MURPHY N, Song M, Papadimitriou N, Carreras-Torres R, et al
    Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis.
    J Natl Cancer Inst. 2022 Jan 20. pii: 6512063. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. ARCHAMBAULT AN, Jeon J, Lin Y, Thomas M, et al
    Risk Stratification for Early-Onset Colorectal Cancer Using a Combination of Genetic and Environmental Risk Scores: An International Multi-Center Study.
    J Natl Cancer Inst. 2022 Jan 13. pii: 6506525. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. SHANKARAN V, Unger JM, Darke AK, Suga JM, et al
    S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients.
    J Natl Cancer Inst. 2022 Jan 4. pii: 6492636. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. GIOVANNUCCI E
    Molecular Biologic and Epidemiologic Insights for Preventability of Colorectal Cancer.
    J Natl Cancer Inst. 2022 Jan 3. pii: 6493343. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2021
38. WERNLY S, Datz C, Wernly B
    RE: Long-Term Colorectal Cancer Incidence and Mortality After Colonoscopy Screening According to Individuals' Risk Profiles.
    J Natl Cancer Inst. 2021 Dec 25. pii: 6483088. doi: 10.1093.
    PubMed    
    
    
    November 2021
39. JIN Z, Dixon JG, Fiskum JM, Parekh HD, et al
    Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database.
    J Natl Cancer Inst. 2021;113:1693-1704.
    PubMed     Abstract available
    
    
    
40. CERCEK A, Chatila WK, Yaeger R, Walch H, et al
    A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers.
    J Natl Cancer Inst. 2021;113:1683-1692.
    PubMed     Abstract available
    
    
    
41. ENG C, Hochster H
    Early-Onset Colorectal Cancer: The Mystery Remains.
    J Natl Cancer Inst. 2021;113:1608-1610.
    PubMed    
    
    
    
42. YIN J, Cohen R, Jin Z, Liu H, et al
    Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer.
    J Natl Cancer Inst. 2021;113:1705-1713.
    PubMed     Abstract available
    
    
    
43. JOSHI AD, Chan AT
    Racial Differences in Epigenetic Aging of the Colon: Implications for Colorectal Cancer.
    J Natl Cancer Inst. 2021;113:1618-1619.
    PubMed    
    
    
    
44. DEVALL M, Sun X, Yuan F, Cooper GS, et al
    Racial Disparities in Epigenetic Aging of the Right vs Left Colon.
    J Natl Cancer Inst. 2021;113:1779-1782.
    PubMed     Abstract available
    
    
    October 2021
45. LIPSYC-SHARF M, Zhang S, Ou FS, Ma C, et al
    Survival in Young-Onset Metastatic Colorectal Cancer: Findings from Cancer and Leukemia Group B (Alliance)/SWOG 80405.
    J Natl Cancer Inst. 2021 Oct 12. pii: 6390822. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2021
46. POST CCB, Stelloo E, Smit VTHBM, Ruano D, et al
    Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer.
    J Natl Cancer Inst. 2021;113:1212-1220.
    PubMed     Abstract available
    
    
    August 2021
47. BREUER E, Hebeisen M, Schneider MA, Roth L, et al
    Site of Recurrence and Survival After Surgery for Colorectal Peritoneal Metastasis.
    J Natl Cancer Inst. 2021;113:1027-1035.
    PubMed     Abstract available
    
    
    April 2021
48. WAGNER AD, Grothey A, Andre T, Dixon JG, et al
    Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database.
    J Natl Cancer Inst. 2021;113:400-407.
    PubMed     Abstract available
    
    
    
49. ZAANAN A, Henriques J, Cohen R, Sefrioui D, et al
    Efficacy of Anti-EGFR in Microsatellite Instability Metastatic Colorectal Cancer Depending on Sporadic or Familial Origin.
    J Natl Cancer Inst. 2021;113:496-500.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.